Philippe Bedard
Project LeaderMOHCCN Network CouncilWorking Group Member
Projects
-
Canadian framework to improve predictive models for immunotherapy interventions (CAN-PREDICT-IT)
Developing multi-modal biomarkers to predict response to specific immunotherapies
Related News
-
PM2 CAN-IMPACT-IO a national immunotherapy biospecimen collection study has now opened
PM2 CAN-IMPACT-IO is a unique national initiative to measure, predict and assess cancer treatment outcomes in patients who have been treated with immunotherapy. Patients on CCTG clinical trials who co... -
Marathon of Hope Cancer Centres Network and Canadian Cancer Trials Group partner on three pan-Canadian projects aimed at making immunotherapy more effective for cancer patients
A new partnership between the Marathon of Hope Cancer Centres Network (MOHCCN) and the Canadian Clinical Trials Group (CCTG) will support three pan-Canadian research teams aiming to better understand ... -
MOHCCN Pan-Canadian Projects underway with announcement of first grant recipients
In total, the Network will fund 20 such groups, representing a multi-million-dollar investment over the next three years that will contribute roughly 6,000 cases to the MOHCCN Gold Cohort, the largest... -
PM2C hosts second event in the MOHCCN Seminar Series
This talk was given on Dec. 6th, 2021 as part of the Marathon of Hope Cancer Centres Seminar Series.
-
Regional Consortia
Princess Margaret Cancer Consortium
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more
-
-
Regional Consortia
Pan-Canadian Projects
Building on work done by Regional Consortia across the country, the Pan-Canadian Projects program unites researchers and clinicians from multiple provinces to work on projects that accelerate precisio...Read more
